首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1547381

全球胎盤幹細胞治療市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Placental Stem Cell Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球胎盤幹細胞治療市場需求預計將從2023年的21.1億美元達到2032年近113.8億美元的市場規模，2024-2032年研究期間的複合年成長率為20.62%。

胎盤幹細胞療法涉及使用源自胎盤的幹細胞來治療各種疾病。胎盤是多能幹細胞的豐富來源，可以在分娩後非侵入性地收集。這些細胞有潛力發育成不同類型的細胞並具有免疫調節特性，使其適用於再生醫學和免疫相關療法。應用包括治療血液疾病、神經系統疾病和組織損傷等疾病。與胚胎幹細胞相比，它具有諸如減少倫理問題以及由於胎盤獨特的免疫學特性而降低免疫排斥風險等優點。

市場動態

慢性和退化性疾病的日益普及推動了胎盤幹細胞治療市場的發展，對先進且有效的治療方案產生了巨大的需求。胎盤幹細胞因其分化成各種細胞類型的能力及其免疫調節特性而具有廣泛的治療潛力。此外，幹細胞研究和再生醫學的進步增強了對胎盤幹細胞的理解和應用，推動了市場成長。與胚胎幹細胞相比，胎盤幹細胞採集的非侵入性和倫理上有利的性質有助於其日益被接受和利用。此外，增加對生物技術和醫療保健領域的投資支持胎盤幹細胞療法的開發和商業化。監管支持和建立健全的臨床試驗框架也促進了市場擴張。人們越來越認知到幹細胞療法的好處及其治療從血液疾病到組織損傷等多種疾病的潛力，這正在推動需求。個人化醫療的日益成長的趨勢，即根據患者個別需求量身定做治療方案，進一步推動了胎盤幹細胞治療市場的發展。然而，倫理問題、監管障礙以及與臨床試驗和商業化相關的高成本可能會阻礙胎盤幹細胞治療市場在未來幾年的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球胎盤幹細胞治療市場的各個細分市場進行了包容性評估。胎盤幹細胞治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

胎盤幹細胞治療市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按申請

血液系統惡性腫瘤和疾病
先天性免疫缺乏症
代謝紊亂
神經系統疾病

按最終用戶

醫院和專科診所
臨床研究組織
院校及院校

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲胎盤幹細胞治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。胎盤幹細胞治療市場的主要參與者包括 Lifebank Stem Cell Banking、Celularity Inc.、Americord Registration、Reelabs Pvt.。 Ltd.、Pluristem Therapeutics Inc.、Mesoblast Limited、ReNeuron Group Plc、Athersys Inc. 本部分包含競爭格局的整體視圖，其中包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：胎盤幹細胞治療公司的競爭格局

胎盤幹細胞治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Lifebank Stem Cell Banking

公司概況
公司收入
產品
最新動態

Celularity Inc.

公司概況
公司收入
產品
最新動態

Americord Registry

公司概況
公司收入
產品
最新動態

Reelabs Pvt. Ltd.

公司概況
公司收入
產品
最新動態

Pluristem Therapeutics Inc.

公司概況
公司收入
產品
最新動態

Mesoblast Limited

公司概況
公司收入
產品
最新動態

ReNeuron Group Plc

公司概況
公司收入
產品
最新動態

Athersys Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215707

The global demand for Placental Stem Cell Therapy Market is presumed to reach the market size of nearly USD 11.38 Billion by 2032 from USD 2.11 Billion in 2023 with a CAGR of 20.62% under the study period 2024-2032.

Placental stem cell therapy involves using stem cells derived from the placenta to treat various medical conditions. The placenta, a rich source of multipotent stem cells, can be harvested non-invasively after childbirth. These cells have the potential to develop into different types of cells and possess immunomodulatory properties, making them suitable for regenerative medicine and immune-related therapies. Applications include treating conditions such as blood disorders, neurological diseases, and tissue injuries. It offers advantages like reduced ethical concerns compared to embryonic stem cells and a lower risk of immune rejection due to the placenta's unique immunological profile.

MARKET DYNAMICS

The placental stem cell therapy market is propelled by the increasing prevalence of chronic and degenerative diseases, creating a significant demand for advanced and effective treatment options. Placental stem cells offer promising therapeutic potential due to their capacity to differentiate into various cell types and their immunomodulatory properties. Additionally, advancements in stem cell research & regenerative medicine enhance the understanding and application of placental stem cells, driving market growth. Compared to embryonic stem cells, the non-invasive and ethically favorable nature of placental stem cell collection contributes to their growing acceptance and utilization. Furthermore, increasing investments in biotechnology and healthcare sectors support the development and commercialization of placental stem cell therapies. Regulatory support and the establishment of robust clinical trial frameworks are also facilitating market expansion. The rising awareness about the benefits of stem cell therapies and their potential to treat a wide range of conditions, from blood disorders to tissue injuries, is driving demand. The increasing trend of personalized medicine, where treatments are customized to individual patient needs, further propels the placental stem cell therapy market. However, ethical concerns, regulatory hurdles, and the high costs associated with clinical trials and commercialization may hinder the growth of the placental stem cell therapy market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Placental Stem Cell Therapy. The growth and trends of Placental Stem Cell Therapy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Placental Stem Cell Therapy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Hematologic Malignancies And Disorders
Congenital Inmunodeficiency Disorders
Metabolic Disorders
Neurological Disorders

By End User

Hospitals & Specialty Clinics
Clinical Research Organizations
Research Institutes & Academies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Placental Stem Cell Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Placental Stem Cell Therapy market include Lifebank Stem Cell Banking, Celularity Inc., Americord Registry, Reelabs Pvt. Ltd., Pluristem Therapeutics Inc., Mesoblast Limited, ReNeuron Group Plc, Athersys Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PLACENTAL STEM CELL THERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By End User
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PLACENTAL STEM CELL THERAPY MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data Analysis By Application
5.3. Hematologic Malignancies And Disorders Historic and Forecast Sales By Regions
5.4. Congenital Inmunodeficiency Disorders Historic and Forecast Sales By Regions
5.5. Metabolic Disorders Historic and Forecast Sales By Regions
5.6. Neurological Disorders Historic and Forecast Sales By Regions

6. GLOBAL PLACENTAL STEM CELL THERAPY MARKET ANALYSIS BY END USER

6.1. Overview By End User
6.2. Historical and Forecast Data Analysis By End User
6.3. Hospitals & Specialty Clinics Historic and Forecast Sales By Regions
6.4. Clinical Research Organizations Historic and Forecast Sales By Regions
6.5. Research Institutes & Academies Historic and Forecast Sales By Regions

7. GLOBAL PLACENTAL STEM CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE PLACENTAL STEM CELL THERAPY COMPANIES

8.1. Placental Stem Cell Therapy Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF PLACENTAL STEM CELL THERAPY INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Lifebank Stem Cell Banking
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Celularity Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Americord Registry
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Reelabs Pvt. Ltd.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Pluristem Therapeutics Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Mesoblast Limited
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. ReNeuron Group Plc
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Athersys Inc
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments